» Articles » PMID: 10101689

Anti-viral Strategies of Cytotoxic T Lymphocytes Are Manifested Through a Variety of Granule-bound Pathways of Apoptosis Induction

Overview
Publisher Wiley
Date 1999 Apr 2
PMID 10101689
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T cells and natural killer cells together constitute a major defence against virus infection, through their ability to induce apoptotic death in infected cells. These cytolytic lymphocytes kill their targets through two principal mechanisms, and one of these, granule exocytosis, is essential for an effective in vivo immune response against many viruses. In recent years, the authors and other investigators have identified several distinct mechanisms that can induce death in a targeted cell. In the present article, it is postulated that the reason for this redundancy of lethal mechanisms is to deal with the array of anti-apoptotic molecules elaborated by viruses to extend the life of infected cells. The fate of such a cell therefore reflects the balance of pro-apoptotic (immune) and anti-apoptotic (viral) strategies that have developed over eons of evolutionary time.

Citing Articles

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.

Chobrutskiy B, Zaman S, Tong W, Diviney A, Blanck G J Neurooncol. 2018; 140(3):697-704.

PMID: 30382482 DOI: 10.1007/s11060-018-03001-1.


HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.

Su L, Hu A, Luo Y, Zhou W, Zhang P, Feng Y Mol Cancer. 2014; 13:178.

PMID: 25060707 PMC: 4126642. DOI: 10.1186/1476-4598-13-178.


Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Omura S, Kawai E, Sato F, Martinez N, Chaitanya G, Rollyson P Circ Cardiovasc Genet. 2014; 7(4):444-54.

PMID: 25031303 PMC: 4332820. DOI: 10.1161/CIRCGENETICS.114.000505.


Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.

Hu A, Dong X, Liu X, Zhang P, Zhang Y, Su N Oncol Lett. 2013; 7(1):115-120.

PMID: 24348831 PMC: 3861564. DOI: 10.3892/ol.2013.1665.


Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model.

Schiffer S, Hansen H, Hehmann-Titt G, Huhn M, Fischer R, Barth S Blood Cancer J. 2013; 3:e106.

PMID: 23524591 PMC: 3615217. DOI: 10.1038/bcj.2013.4.